Active	Status	Sponsor type	Region	Phase	Filter
12 Active 9 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Combs, Stephanie E
INTRAGO-II, NCT02685605: Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme	Active, not recruiting	3	314	Europe, Canada, US, RoW	Standard surgery, Intraoperative radiotherapy, IORT, Radiochemotherapy, Temozolomide	Universitätsmedizin Mannheim, Carl Zeiss Meditec AG, University of California, Los Angeles	Glioblastoma	06/24	06/26
NANORAY-312, NCT04892173 / 2021-002163-22: NBTXR3 With or Without Cetuximab in LA-HNSCC	Recruiting	3	500	Europe, Canada, Japan, US, RoW	NBTXR3, Functionalized hafnium oxide nanoparticles, Cetuximab, Erbitux, Radiation Therapy	Nanobiotix, Nanobiotix SA	Locally Advanced Head and Neck Squamous Cell Carcinoma, Aged	06/26	06/27